191 related articles for article (PubMed ID: 28650467)
1. Genome-wide loss-of-function genetic screening identifies opioid receptor μ1 as a key regulator of L-asparaginase resistance in pediatric acute lymphoblastic leukemia.
Kang SM; Rosales JL; Meier-Stephenson V; Kim S; Lee KY; Narendran A
Oncogene; 2017 Oct; 36(42):5910-5913. PubMed ID: 28650467
[TBL] [Abstract][Full Text] [Related]
2. PKA inhibition kills L-asparaginase-resistant leukemic cells from relapsed acute lymphoblastic leukemia patients.
Lee JK; Wang X; Wang J; Rosales JL; Lee KY
Cell Death Discov; 2024 May; 10(1):257. PubMed ID: 38802344
[TBL] [Abstract][Full Text] [Related]
3. HAP1 loss confers l-asparaginase resistance in ALL by downregulating the calpain-1-Bid-caspase-3/12 pathway.
Lee JK; Kang S; Wang X; Rosales JL; Gao X; Byun HG; Jin Y; Fu S; Wang J; Lee KY
Blood; 2019 May; 133(20):2222-2232. PubMed ID: 30819925
[TBL] [Abstract][Full Text] [Related]
4. D,L-Methadone causes leukemic cell apoptosis via an OPRM1-triggered increase in IP3R-mediated ER Ca
Lee J; Rosales JL; Byun HG; Lee KY
Sci Rep; 2021 Jan; 11(1):1009. PubMed ID: 33441856
[TBL] [Abstract][Full Text] [Related]
5. A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.
Fine BM; Kaspers GJ; Ho M; Loonen AH; Boxer LM
Cancer Res; 2005 Jan; 65(1):291-9. PubMed ID: 15665306
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.
Iwamoto S; Mihara K; Downing JR; Pui CH; Campana D
J Clin Invest; 2007 Apr; 117(4):1049-57. PubMed ID: 17380207
[TBL] [Abstract][Full Text] [Related]
7. Recent developments in L-asparaginase discovery and its potential as anticancer agent.
Shrivastava A; Khan AA; Khurshid M; Kalam MA; Jain SK; Singhal PK
Crit Rev Oncol Hematol; 2016 Apr; 100():1-10. PubMed ID: 25630663
[TBL] [Abstract][Full Text] [Related]
8. Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance.
Chen SH
Pediatr Neonatol; 2015 Oct; 56(5):287-93. PubMed ID: 25603726
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL.
Stams WA; den Boer ML; Beverloo HB; Meijerink JP; Stigter RL; van Wering ER; Janka-Schaub GE; Slater R; Pieters R
Blood; 2003 Apr; 101(7):2743-7. PubMed ID: 12433682
[TBL] [Abstract][Full Text] [Related]
10. Biological characteristics and prognostic value of in vitro three-drug resistance to prednisolone, L-asparaginase, and vincristine in childhood acute lymphoblastic leukemia.
Hongo T; Yamada S; Yajima S; Watanabe C; Fujii Y; Kawasaki H; Yazaki M; Hanada R; Horikoshi Y
Int J Hematol; 1999 Dec; 70(4):268-77. PubMed ID: 10643153
[TBL] [Abstract][Full Text] [Related]
11. Metabolic profile of leukemia cells influences treatment efficacy of L-asparaginase.
Hlozkova K; Pecinova A; Alquezar-Artieda N; Pajuelo-Reguera D; Simcikova M; Hovorkova L; Rejlova K; Zaliova M; Mracek T; Kolenova A; Stary J; Trka J; Starkova J
BMC Cancer; 2020 Jun; 20(1):526. PubMed ID: 32503472
[TBL] [Abstract][Full Text] [Related]
12. An inhibitor of human asparagine synthetase suppresses proliferation of an L-asparaginase-resistant leukemia cell line.
Gutierrez JA; Pan YX; Koroniak L; Hiratake J; Kilberg MS; Richards NG
Chem Biol; 2006 Dec; 13(12):1339-47. PubMed ID: 17185229
[TBL] [Abstract][Full Text] [Related]
13. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
Li Y; Buijs-Gladdines JG; Canté-Barrett K; Stubbs AP; Vroegindeweij EM; Smits WK; van Marion R; Dinjens WN; Horstmann M; Kuiper RP; Buijsman RC; Zaman GJ; van der Spek PJ; Pieters R; Meijerink JP
PLoS Med; 2016 Dec; 13(12):e1002200. PubMed ID: 27997540
[TBL] [Abstract][Full Text] [Related]
14. IGFBP7 participates in the reciprocal interaction between acute lymphoblastic leukemia and BM stromal cells and in leukemia resistance to asparaginase.
Laranjeira AB; de Vasconcellos JF; Sodek L; Spago MC; Fornazim MC; Tone LG; Brandalise SR; Nowill AE; Yunes JA
Leukemia; 2012 May; 26(5):1001-11. PubMed ID: 22005787
[TBL] [Abstract][Full Text] [Related]
15. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
[TBL] [Abstract][Full Text] [Related]
16. Hypomethylation and reactivation of the asparagine synthetase gene induced by L-asparaginase and ethyl methanesulfonate.
Worton KS; Kerbel RS; Andrulis IL
Cancer Res; 1991 Feb; 51(3):985-9. PubMed ID: 1703043
[TBL] [Abstract][Full Text] [Related]
17. Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase.
Hermanova I; Zaliova M; Trka J; Starkova J
Exp Hematol; 2012 Aug; 40(8):657-65. PubMed ID: 22542578
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginase.
Asselin BL; Ryan D; Frantz CN; Bernal SD; Leavitt P; Sallan SE; Cohen HJ
Cancer Res; 1989 Aug; 49(15):4363-8. PubMed ID: 2743326
[TBL] [Abstract][Full Text] [Related]
19. Use of L-asparaginase in acute lymphoblastic leukemia: recommendations of the Polish Adult Leukemia Group.
Piatkowska-Jakubas B; Krawczyk-Kuliś M; Giebel S; Adamczyk-Cioch M; Czyz A; Lech Marańda E; Paluszewska M; Pałynyczko G; Piszcz J; Hołowiecki J;
Pol Arch Med Wewn; 2008 Nov; 118(11):664-9. PubMed ID: 19140571
[TBL] [Abstract][Full Text] [Related]
20. L-Asparaginase delivery systems targeted to minimize its side-effects.
Talluri VP; Mutaliyeva B; Sharipova A; Ulaganathan V; Lanka SS; Aidarova S; Suigenbayeva A; Tleuova A
Adv Colloid Interface Sci; 2023 Jun; 316():102915. PubMed ID: 37159987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]